CTOs on the Move

X4 Pharmaceuticals

www.x4pharma.com

 
X4 Pharmaceuticals (Nasdaq: XFOR) is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company`s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. X4`s most advanced product candidate, mavorixafor (X4P-001), is in a global Phase 3 pivotal trial in patients with WHIM syndrome, a rare, inherited, primary immunodeficiency disease, and is currently also under investigation in combination with axitinib in the Phase 2a portion of an open-label Phase 1/2 clinical trial in clear cell renal cell carcinoma (ccRCC). X4 is ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.x4pharma.com
  • 955 Massachusetts Avenue 4th Floor
    Cambridge, MA USA 02139
  • Phone: 857.529.8300

Executives

Name Title Contact Details
Patrick Breznak
Director - IT Operations, Infastructure, Security Profile

Funding

X4 Pharmaceuticals raised $37.5M on 08/28/2015
X4 Pharmaceuticals raised $27M on 11/16/2017
X4 Pharmaceuticals raised $55M on 03/19/2021

Similar Companies

SwitchGear Genomics (Main)

SwitchGear Genomics (Main) is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

I Holland Americas

I Holland Americas is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rochester Clinical Research

Rochester Clinical Research is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hoechst AG

Hoechst AG is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.